Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents

Targeted covalent inhibitors hold promise for drug discovery, particularly for kinases. Targeting the catalytic lysine of epidermal growth factor receptor (EGFR) has attracted attention as a new strategy to overcome resistance due to the emergence of C797S mutation. Sulfonyl fluoride derivatives able to inhibit EGFRL858R/T790M/C797S by sulfonylation of Lys745 have been reported. However, atomistic details of this process are still poorly understood. Here, we describe the mechanism of inhibition of an innovative class of compounds that covalently engage the catalytic lysine of EGFR, through a sulfur(VI) fluoride exchange (SuFEx) process, with the help of hybrid quantum mechanics/molecular mechanics (QM/MM) and path collective variables (PCVs) approaches. Our simulations identify the chemical determinants accounting for the irreversible activity of agents targeting Lys745 and provide hints for the further optimization of sulfonyl fluoride agents.

[1]  Ewa I. Chudyk,et al.  QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases , 2022, ACS infectious diseases.

[2]  Ayşegül Özen,et al.  Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer , 2022, Journal of medicinal chemistry.

[3]  L. Ouyang,et al.  Emerging strategies to overcome resistance to third-generation EGFR inhibitors , 2022, Journal of Hematology & Oncology.

[4]  M. Mor,et al.  Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency , 2022, J. Chem. Inf. Model..

[5]  K. Rittinger,et al.  Profiling Sulfur(VI) Fluorides as Reactive Functionalities for Chemical Biology Tools and Expansion of the Ligandable Proteome , 2022, ACS chemical biology.

[6]  M. Mor,et al.  Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors , 2021, J. Chem. Inf. Model..

[7]  M. Tiseo,et al.  A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine. , 2021, European journal of medicinal chemistry.

[8]  M. Tiseo,et al.  Fighting tertiary mutations in EGFR-driven lung-cancers: current advances and future perspectives in medicinal chemistry. , 2021, Biochemical pharmacology.

[9]  K. Sharpless,et al.  Sulfur [18F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis. , 2021, Journal of the American Chemical Society.

[10]  Levente M. Mihalovits,et al.  Affinity and Selectivity Assessment of Covalent Inhibitors by Free Energy Calculations , 2020, J. Chem. Inf. Model..

[11]  Shan Xu,et al.  The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation. , 2020, European journal of medicinal chemistry.

[12]  M. Mor,et al.  N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations , 2020 .

[13]  A. Mulholland,et al.  Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity , 2020, Chemical science.

[14]  N. Lehnert,et al.  Catalysis by the JmjC histone demethylase KDM4A integrates substrate dynamics, correlated motions and molecular orbital control† , 2020, Chemical science.

[15]  S. Laufer,et al.  Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors. , 2020, Journal of medicinal chemistry.

[16]  J. Kelly,et al.  Structure-based design and analysis of SuFEx chemical probes. , 2020, RSC medicinal chemistry.

[17]  Ying Cheng,et al.  Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. , 2019, The New England journal of medicine.

[18]  E. Giovannetti,et al.  Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer , 2019, British Journal of Cancer.

[19]  D. Wolan,et al.  SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase , 2019, Proceedings of the National Academy of Sciences.

[20]  Jana K. Shen,et al.  How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase. , 2019, Journal of the American Chemical Society.

[21]  J. Taunton,et al.  Lysine-Targeted Inhibitors and Chemoproteomic Probes. , 2019, Annual review of biochemistry.

[22]  Jana K. Shen,et al.  Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors. , 2019, Journal of the American Chemical Society.

[23]  S. Laufer,et al.  Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. , 2018, Journal of medicinal chemistry.

[24]  D. Rauh,et al.  C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer? , 2018, ACS medicinal chemistry letters.

[25]  R. Lonsdale,et al.  Structure-based design of targeted covalent inhibitors. , 2018, Chemical Society reviews.

[26]  H. Mukherjee,et al.  Beyond cysteine: recent developments in the area of targeted covalent inhibition. , 2018, Current opinion in chemical biology.

[27]  Keith Jones,et al.  Lysine-Targeting Covalent Inhibitors. , 2017, Angewandte Chemie.

[28]  A. Whitty,et al.  A study of the reactivity of S(VI)-F containing warheads with nucleophilic amino-acid side chains under physiological conditions. , 2017, Organic & biomolecular chemistry.

[29]  A. Burlingame,et al.  Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes. , 2017, Journal of the American Chemical Society.

[30]  I. Wilson,et al.  Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue. , 2016, Journal of the American Chemical Society.

[31]  Javier Setoain,et al.  MEPSA: minimum energy pathway analysis for energy landscapes , 2015, Bioinform..

[32]  Aleksandra Markovets,et al.  Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M , 2015, Nature Medicine.

[33]  Alessio Lodola,et al.  Quantum Mechanics/Molecular Mechanics Modeling of Covalent Addition between EGFR-Cysteine 797 and N-(4-Anilinoquinazolin-6-yl) Acrylamide , 2015, J. Chem. Inf. Model..

[34]  V. Moliner,et al.  Binding isotope effects as a tool for distinguishing hydrophobic and hydrophilic binding sites of HIV-1 RT. , 2015, The journal of physical chemistry. B.

[35]  Peter Ballard,et al.  Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor. , 2014, Journal of medicinal chemistry.

[36]  Younan Xia,et al.  Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. , 2014, Angewandte Chemie.

[37]  Massimiliano Bonomi,et al.  PLUMED 2: New feathers for an old bird , 2013, Comput. Phys. Commun..

[38]  M. W. van der Kamp,et al.  Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology. , 2013, Biochemistry.

[39]  A. Cavalli,et al.  A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations , 2012, PloS one.

[40]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[41]  Ikchoon Lee,et al.  Theoretical studies of the nucleophilic substitution of halides and amine at a sulfonyl center. , 2009, The journal of physical chemistry. A.

[42]  J. Pople,et al.  Variational configuration interaction methods and comparison with perturbation theory , 2009 .

[43]  Massimiliano Bonomi,et al.  PLUMED: A portable plugin for free-energy calculations with molecular dynamics , 2009, Comput. Phys. Commun..

[44]  Walter Thiel,et al.  QM/MM methods for biomolecular systems. , 2009, Angewandte Chemie.

[45]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[46]  J. Stewart.  Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements , 2007, Journal of molecular modeling.

[47]  Francesco Luigi Gervasio,et al.  From A to B in free energy space. , 2007, The Journal of chemical physics.

[48]  Preston Moore,et al.  Metadynamics as a tool for exploring free energy landscapes of chemical reactions. , 2006, Accounts of chemical research.

[49]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[50]  H. Lane,et al.  ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.

[51]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[52]  Yong Duan,et al.  Distinguish protein decoys by Using a scoring function based on a new AMBER force field, short molecular dynamics simulations, and the generalized born solvent model , 2004, Proteins.

[53]  M. Page.  Beta-sultams-mechanism of reactions and use as inhibitors of serine proteases. , 2004, Accounts of chemical research.

[54]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[55]  K. Schulten,et al.  Free energy calculation from steered molecular dynamics simulations using Jarzynski's equality , 2003 .

[56]  John Mendelsohn,et al.  The EGF receptor family as targets for cancer therapy , 2000, Oncogene.

[57]  Martin J. Field,et al.  The dynamo library for molecular simulations using hybrid quantum mechanical and molecular mechanical potentials , 2000, J. Comput. Chem..

[58]  C. Jarzynski.  Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.

[59]  P. Tavan,et al.  Ligand Binding: Molecular Mechanics Calculation of the Streptavidin-Biotin Rupture Force , 1996, Science.

[60]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[61]  M. Karplus,et al.  A combined quantum mechanical and molecular mechanical potential for molecular dynamics simulations , 1990 .

[62]  J. Stewart.  Optimization of parameters for semiempirical methods I. Method , 1989 .

[63]  J. Stewart.  Optimization of parameters for semiempirical methods II. Applications , 1989 .

[64]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[65]  R. Bartlett.  Many-Body Perturbation Theory and Coupled Cluster Theory for Electron Correlation in Molecules , 1981 .

[66]  G. Torrie,et al.  Nonphysical sampling distributions in Monte Carlo free-energy estimation: Umbrella sampling , 1977 .

[67]  M. Plesset,et al.  Note on an Approximation Treatment for Many-Electron Systems , 1934 .

[68]  M. Mor,et al.  Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations. , 2020, Methods in molecular biology.

[69]  Adrian J Mulholland,et al.  Computational enzymology. , 2010, Chemical communications.

[70]  E. Catmull,et al.  A CLASS OF LOCAL INTERPOLATING SPLINES , 1974 .